Recent insights into viral infections as a trigger and accelerator in alzheimer's disease

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder for which only symptomatic medication is available, except for the recently FDA-approved aducanumab. This lack of effective treatment urges us to investigate alternative paths that might contribute to disease development. In light...

Descripción completa

Detalles Bibliográficos
Autores principales: De Vlieger, Lize, Vandenbroucke, Roosmarijn E., Van Hoecke, Lien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Keynote (Green)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385395/
https://www.ncbi.nlm.nih.gov/pubmed/35987492
http://dx.doi.org/10.1016/j.drudis.2022.103340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385395/
https://www.ncbi.nlm.nih.gov/pubmed/35987492
http://dx.doi.org/10.1016/j.drudis.2022.103340

Ejemplares similares